Patents Assigned to Merck Patents GmbH
  • Publication number: 20200123388
    Abstract: Effect pigments based on Al2O3 flakes with high weather resistance and less photoactivity and to their use thereof in paints, industrial coatings, automotive coatings, printing inks, cosmetic formulations. The effect pigments have a ratio of the amount by weight of Al2O3 of the Al2O3 flake and the amount by weight of the metal oxide(s) of the coating layer(s) in the range of from 27:73 to 83:17 based on the total weight of the effect pigment.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 23, 2020
    Applicant: Merck Patent GmbH
    Inventors: Sabine SCHOEN, Michael JUNGNITZ, Stefan SCHLUETER, Kirsten FRITSCHE, Carsten PLUEG, Stephanie ANDES, Ulrich SCHOENEFELD
  • Publication number: 20200121788
    Abstract: Methods of treatment of colorectal cancer can include the administration of the anti-alpha-v integrin (receptor) antibody Abituzumab. Preferably, the methods of treating colorectal cancer can include treating Stage II-IV colorectal cancer, metastatic colorectal cancer, left-sided colorectal cancer and/or left-sided metastatic colorectal cancer, involving the administration of said Abituzumab to patients in need thereof. Abituzumab is also useful for the manufacture of a medicament for treating colorectal cancer, preferably colorectal cancer as defined herein. Abituzumab is further useful for the manufacture of a medicament for treating colorectal cancer in combination with suitable targeted therapy concepts, such as growth factor or growth factor receptor targeting monoclonal antibodies, and/or chemotherapy.
    Type: Application
    Filed: October 18, 2019
    Publication date: April 23, 2020
    Applicant: Merck Patent GmbH
    Inventors: Giorgio MASSIMINI, Ilhan Celik, Josef Straub, Rolf Bruns
  • Publication number: 20200123144
    Abstract: An anhydrous disordered crystalline (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)-phenyl]-(6-methoxy-pyridazin-3-yl)-methanol can be used in pharmaceutical compositions.
    Type: Application
    Filed: March 28, 2018
    Publication date: April 23, 2020
    Applicant: Merck Patent GmbH
    Inventors: Michael Lange, Clemens Kuehn, Thomas Fuchss, David Maillard, Marcel Breuning, Marco Poma, Edoardo Burini
  • Patent number: 10629817
    Abstract: The present invention relates to the fluorene derivatives and to organic electronic devices in which these Compounds are used as matrix material in the emitting layer and/or as hole transport material and/or as electron blocker or exciton blocker material and/or as electron transport material.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: April 21, 2020
    Assignee: Merck Patent GmbH
    Inventors: Dominik Joosten, Florian Maier-Flaig, Anna Hayer, Holger Heil
  • Patent number: 10626364
    Abstract: The present invention relates to the use of sulfocysteine and derivatives thereof to increase the gluthathione pool in cells.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: April 21, 2020
    Assignee: Merck Patent GmbH
    Inventor: Aline Zimmer
  • Patent number: 10626666
    Abstract: The present application relates to a device for regulating the passage of light which is characterised in that it comprises a layer comprising a liquid-crystalline mixture containing a characteristic structural element.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 21, 2020
    Assignee: Merck Patent GmbH
    Inventors: Michael Junge, Andreas Beyer, Ursula Patwal, Peer Kirsch, Susann Beck
  • Patent number: 10626330
    Abstract: The invention relates to a method of manufacturing a liquid crystal display device wherein a liquid crystal mixture having positive dielectric anisotropy or negative dielectric anisotropy is interposed between a first substrate and a second substrate, the liquid crystal mixture comprising liquid crystal molecules, a self assembling photoalignment agent, a polymerisable compound, and wherein said LC mixture is photoaligned by irradiation with linearly polarised ultraviolet light and then cured by irradiation with ultraviolet light.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: April 21, 2020
    Assignee: MERCK PATENT GMBH
    Inventors: Kevin Adlem, Alex Davis, Rachel Tuffin, Mark Goebel, Graziano Archetti, Rocco Fortte, Karl Skjonnemand, Ian Charles Sage
  • Publication number: 20200115387
    Abstract: The invention relates to novel organic semiconducting compounds containing a polycyclic unit, to methods for their preparation and educts or intermediates used therein, to compositions and formulations containing them, to the use of the compounds and compositions as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, organic photodetectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE devices comprising these compounds or compositions.
    Type: Application
    Filed: July 5, 2017
    Publication date: April 16, 2020
    Applicant: Merck Patent GmbH
    Inventors: William MITCHELL, Mansoor D'LAVARI, Changsheng WANG
  • Patent number: 10622565
    Abstract: The present invention describes carbazole, dibenzofuran, dibenzothiophene and fluorene derivatives which are substituted by electron-deficient heteroaryl groups, in particular for use as triplet matrix materials in organic electroluminescent devices. The invention furthermore relates to a process for the preparation of the compounds according to the invention and to electronic devices comprising these compounds.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: April 14, 2020
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Anja Jatsch, Thomas Eberle, Tobias Grossmann, Jonas Valentin Kroeber, Lars Dobelmann-Mara
  • Patent number: 10622567
    Abstract: The present invention relates to compounds according to formula (1) and formula (2), said compounds being suitable for use in electronic devices, in particular organic electroluminescent devices.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: April 14, 2020
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Christof Pflumm, Anja Jatsch, Thomas Eberle, Jonas Valentin Kroeber
  • Patent number: 10619131
    Abstract: The present invention relates to cell culture media comprising inorganic ester derivatives of tyrosine and/or cysteine. The poor solubility of tyrosine and the often non-sufficient stability of cysteine in cell culture media is overcome by substituting them with an inorganic ester derivative, e.g. with a phosphorylated derivative.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: April 14, 2020
    Assignee: Merck Patent GmbH
    Inventors: Joerg Von Hagen, Marcel Andre Breuning, Christian Jasper
  • Patent number: 10617975
    Abstract: The present invention refers to a method for the separation of peptide aggregates and fragments from solutions containing target peptide.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: April 14, 2020
    Assignee: MERCK PATENT GMBH
    Inventors: Romas Skudas, Klaus Adrian, Bianca Edelmann, Matthias Joehnck
  • Publication number: 20200108211
    Abstract: Disclosed herein is an auto injector assembly comprising an auto injector for dose injection of medicament and a protective casing covering the auto injector, the auto injector having a recap prevention cap with one or more recap prevention springs and a housing partly protruding through the recap prevention cap. The housing is for accommodation of a syringe with a needle, a plunger rod, a plunger rod, a syringe driver, and a plunger rod driver.
    Type: Application
    Filed: May 16, 2018
    Publication date: April 9, 2020
    Applicant: MERCK PATENT GMBH
    Inventor: Peter Blaabjerg JACOBSEN
  • Patent number: 10611963
    Abstract: The present invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy (??), which is distinguished by the fact that it has a value for the ratio ?1/?n2 in the range 6-45 with a clearing point of >60° C. and a ?? of ??2.3. Media of this type are particularly suitable for electro-optical displays having active-matrix addressing based on the ECB, PA LCD, FFS or IPS effect.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: April 7, 2020
    Assignee: Merck Patent GmbH
    Inventors: Melanie Klasen-Memmer, Sabine Schoen
  • Patent number: 10613442
    Abstract: The present invention is a charge complexing chemical composition that protects metal during polymer removal. The polymer coatings include crosslinked systems by chemical-amplification and photoacid generated (PAG) means as in epoxies. The system includes a solvent, a charge complexing additive, and an acid that creates a protective complex for sensitive metals during the dissolving and rinsing practice needed for processing microelectronic parts. The composition can be utilized with a method for removing partial and fully cured crosslinked coatings that originate from chemical amplification or PAG-epoxy photoimageable coatings.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: April 7, 2020
    Assignee: Merck Patent GmbH
    Inventor: John Cleaon Moore
  • Patent number: 10615343
    Abstract: The present invention relates to a formulation comprising at least one organofunctional material which can be employed for the production of functional layers of electronic devices, and at least one aromatic compound. The present invention furthermore relates to electronic devices which are obtainable from these formulations.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: April 7, 2020
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Irina Martynova, Aurélie Ludemann, Edgar Kluge, Nils Koenen
  • Publication number: 20200102499
    Abstract: A liquid-crystalline medium containing one or more compounds of formula IA, and the use thereof in an active-matrix display, in particular in a VA, IPS, U-IPS, FFS, UB-FFS, SA-VA, SA-FFS, PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA, PS-TN, polymer stabilised SA-VA or polymer stabilised SA-FFS display.
    Type: Application
    Filed: September 26, 2019
    Publication date: April 2, 2020
    Applicant: Merck Patent GmbH
    Inventors: Martin ENGEL, Sebastian HOFMEYER, Christoph MARTEN, Lars LIETZAU
  • Publication number: 20200101399
    Abstract: A method and an apparatus suitable for a continuous chromatography process which only needs three separation columns, and a two-step process containing two chromatographic steps, in which the first chromatographic step (capture) is performed alternating and sequentially on two separation columns, the second chromatographic step (polishing) is performed, also sequentially, on the third column.
    Type: Application
    Filed: October 29, 2019
    Publication date: April 2, 2020
    Applicant: Merck Patent GmbH
    Inventor: Romas SKUDAS
  • Publication number: 20200102494
    Abstract: The present invention relates to a method for synthesizing a semiconducting nanosized material.
    Type: Application
    Filed: May 22, 2018
    Publication date: April 2, 2020
    Applicant: MERCK PATENT GMBH
    Inventors: David MOCATTA, Amir HOLTZMAN, Inbal DAVIDI, Shany NEYSHTADT
  • Patent number: 10604703
    Abstract: The present invention relates to mesogenic media and to electro-optical displays comprising these media as light modulation media. In particular, the electro-optical displays according to the present invention are displays, which are operated at a temperature, at which the mesogenic modulation media are in an optically isotropic phase, preferably in a blue phase.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: March 31, 2020
    Assignee: MERCK PATENT GMBH
    Inventors: Michael Wittek, Mathias Bremer, Edward Plummer, Mila Fischer, Harald Lannert, Volker Meyer